This month, we’re honing in on the intersecting medical and additive manufacturing industries . Primarily, we’re looking at how AM applications in the medical sector are providing new opportunities and benefits for patient care, but it is also important to look at the limitations that still exist with 3D printing in healthcare.

 .

An interesting bit of research coming out of University College London highlights these limitations perfectly in the area of 3D printed medication. Researchers at University College London have played a pivotal role in the development of 3D printed pills.

 .

Specifically, Simon Gaisford, a Professor of Pharmaceuticals, has led innovative research in the use of SLA 3D printing for producing pills with custom doses. This research, as some will know, resulted in the formation of a spin-off company dedicated to printing medication, FabRx . FabRx’s work has proven that SLA 3D printing is viable for printing polypills with […]

Click here to view original web page at www.3dprintingmedia.network